Cargando…
Gas transport during in vitro and in vivo preclinical testing of inert gas therapies
New gas therapies using inert gases such as xenon and argon are being studied, which require in vitro and in vivo preclinical experiments. Examples of the kinetics of gas transport during such experiments are analyzed in this paper. Using analytical and numerical models, we analyze an in vitro exper...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075678/ https://www.ncbi.nlm.nih.gov/pubmed/27826419 http://dx.doi.org/10.4103/2045-9912.179342 |
_version_ | 1782461907891912704 |
---|---|
author | Katz, Ira Palgen, Marc Murdock, Jacqueline Martin, Andrew R. Farjot, Géraldine Caillibotte, Georges |
author_facet | Katz, Ira Palgen, Marc Murdock, Jacqueline Martin, Andrew R. Farjot, Géraldine Caillibotte, Georges |
author_sort | Katz, Ira |
collection | PubMed |
description | New gas therapies using inert gases such as xenon and argon are being studied, which require in vitro and in vivo preclinical experiments. Examples of the kinetics of gas transport during such experiments are analyzed in this paper. Using analytical and numerical models, we analyze an in vitro experiment for gas transport to a 96 cell well plate and an in vivo delivery to a small animal chamber, where the key processes considered are the wash-in of test gas into an apparatus dead volume, the diffusion of test gas through the liquid media in a well of a cell test plate, and the pharmacokinetics in a rat. In the case of small animals in a chamber, the key variable controlling the kinetics is the chamber wash-in time constant that is a function of the chamber volume and the gas flow rate. For cells covered by a liquid media the diffusion of gas through the liquid media is the dominant mechanism, such that liquid depth and the gas diffusion constant are the key parameters. The key message from these analyses is that the transport of gas during preclinical experiments can be important in determining the true dose as experienced at the site of action in an animal or to a cell. |
format | Online Article Text |
id | pubmed-5075678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50756782016-11-08 Gas transport during in vitro and in vivo preclinical testing of inert gas therapies Katz, Ira Palgen, Marc Murdock, Jacqueline Martin, Andrew R. Farjot, Géraldine Caillibotte, Georges Med Gas Res Research Article New gas therapies using inert gases such as xenon and argon are being studied, which require in vitro and in vivo preclinical experiments. Examples of the kinetics of gas transport during such experiments are analyzed in this paper. Using analytical and numerical models, we analyze an in vitro experiment for gas transport to a 96 cell well plate and an in vivo delivery to a small animal chamber, where the key processes considered are the wash-in of test gas into an apparatus dead volume, the diffusion of test gas through the liquid media in a well of a cell test plate, and the pharmacokinetics in a rat. In the case of small animals in a chamber, the key variable controlling the kinetics is the chamber wash-in time constant that is a function of the chamber volume and the gas flow rate. For cells covered by a liquid media the diffusion of gas through the liquid media is the dominant mechanism, such that liquid depth and the gas diffusion constant are the key parameters. The key message from these analyses is that the transport of gas during preclinical experiments can be important in determining the true dose as experienced at the site of action in an animal or to a cell. Medknow Publications & Media Pvt Ltd 2016-04-04 /pmc/articles/PMC5075678/ /pubmed/27826419 http://dx.doi.org/10.4103/2045-9912.179342 Text en Copyright: © 2016 Medical Gas Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Katz, Ira Palgen, Marc Murdock, Jacqueline Martin, Andrew R. Farjot, Géraldine Caillibotte, Georges Gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
title | Gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
title_full | Gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
title_fullStr | Gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
title_full_unstemmed | Gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
title_short | Gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
title_sort | gas transport during in vitro and in vivo preclinical testing of inert gas therapies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075678/ https://www.ncbi.nlm.nih.gov/pubmed/27826419 http://dx.doi.org/10.4103/2045-9912.179342 |
work_keys_str_mv | AT katzira gastransportduringinvitroandinvivopreclinicaltestingofinertgastherapies AT palgenmarc gastransportduringinvitroandinvivopreclinicaltestingofinertgastherapies AT murdockjacqueline gastransportduringinvitroandinvivopreclinicaltestingofinertgastherapies AT martinandrewr gastransportduringinvitroandinvivopreclinicaltestingofinertgastherapies AT farjotgeraldine gastransportduringinvitroandinvivopreclinicaltestingofinertgastherapies AT caillibottegeorges gastransportduringinvitroandinvivopreclinicaltestingofinertgastherapies |